Cell Transplantation

Subscribe to Selected New Research on Cell Transplantation

1179 relevant articles (67 outcomes, 110 trials/studies) found for this Therapy

Description: Transference of cells within an individual, between individuals of the same species, or between individuals of different species.

Also Known As:

Transplantation, Cell; Cell Transplantations; Transplantations, Cell

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Transplantation: 36685

Cell Transplantation: 1179

Stem Cell Transplantation: 4630

Islets of Langerhans Transplantation: 358

Experts

1.	Storb, Rainer: 34 articles (05/2008 - 07/2003)
2.	Sandmaier, Brenda M: 21 articles (02/2008 - 02/2003)
3.	Deeg, H Joachim: 16 articles (05/2008 - 05/2003)
4.	Maloney, David G: 16 articles (02/2008 - 02/2003)
5.	Appelbaum, Frederick R: 15 articles (06/2008 - 04/2002)
6.	Maris, Michael B: 14 articles (02/2008 - 09/2003)
7.	Forman, Stephen J: 13 articles (10/2008 - 09/2004)
8.	Martin, Paul J: 13 articles (05/2008 - 12/2003)
9.	Storer, Barry E: 12 articles (02/2008 - 02/2004)
10.	Blume, Karl G: 11 articles (08/2008 - 02/2003)

Related Diseases

1.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/01/2007 - "RECENT FINDINGS: Early results with allogeneic hematopoietic cell transplantation after nonmyeloablative and reduced-intensity conditioning for patients with acute myeloid leukemia in first complete remission are encouraging, with 2-year survivals after hematopoietic cell transplantation ranging from 48 to 79% among studies" 03/01/2007 - "SUMMARY: Prospective studies are needed to define the place of allogeneic hematopoietic cell transplantation after nonmyeloablative or reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission, and to determine a role for consolidation chemotherapy before hematopoietic cell transplantation, if any." 03/01/2007 - "Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission." 03/01/2007 - "Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission." 06/01/2004 - "On the basis of transplantation data from the Japan Society for Hematopoietic Cell Transplantation, we retrospectively analyzed the impact of cytogenetics at diagnosis on the outcome of transplantation in 628 patients with acute myeloid leukemia who underwent autologous (n = 200), allogeneic related (n = 363), or allogenic unrelated (n = 65) stem cell transplantation (SCT) at first complete remission" Order ALL the reference details at left...
2.	Myocardial Infarction 08/30/2005 - "BACKGROUND: Cell transplantation offers the promise in the restoration of ventricular function after an extensive myocardial infarction, but the optimal cell type remains controversial" 09/01/2006 - "BACKGROUND: Recently, several preliminary reports have demonstrated that cell transplantation after acute myocardial infarction in humans is safe and leads to better preserved left ventricular function and improved myocardial perfusion and coronary flow reserve" 08/30/2005 - "CONCLUSIONS: Engrafted USSCs were detected in the infarct region 4 weeks after cell transplantation, and the implanted cells improved regional and global function of the porcine heart after a myocardial infarction" 06/01/2003 - "BACKGROUND: While neonatal cell transplantation improved function for acute myocardial infarction, long-term data on the effects of cell-transplant therapy using a more primitive cell on ventricular remodeling and function are needed" 01/01/2000 - "CONCLUSION: Autologous porcine heart cell transplantation improved regional perfusion and global ventricular function after a myocardial infarction." Order ALL the reference details at left...
3.	Graft vs Host Disease (Graft-Versus-Host Disease) 02/01/2005 - "The efficacy of allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning depends on the balance between the desirable antineoplastic effects of donor cells weighed against the undesirable morbidity of graft-versus-host disease (GVHD)" 10/15/2006 - "The aim of this study was to understand the impact of chronic graft-versus-host disease (cGVHD) on the overall health status of hematopoietic cell transplantation (HCT) survivors" 10/15/2006 - "Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study." 08/01/2006 - "OBJECTIVE: To study the potential relationship between HHV-6 activation and acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic cell transplantation (HSCT)" 08/01/2005 - "Separate trials of the potential utility of these agents, particularly in the reduction of graft-versus-host disease, in the setting of hematopoietic cell transplantation have yielded encouraging results" Order ALL the reference details at left...
4.	Hematologic Neoplasms (Hematological Malignancy) 01/01/2006 - "Allogeneic hematopoietic cell transplantation (HCT) after myeloablative conditioning regimens has been an effective treatment for many patients with hematologic malignancies or inherited blood disorders" 01/01/2008 - "Recent development of hematopoietic cell transplantation (HCT) has greatly improved the quality of life in critical patients with hematological malignancies" 08/01/2006 - "The outcome of hematopoietic cell transplantation for hematologic malignancies may be improved by delivering targeted radiation to hematopoietic organs while relatively sparing nontarget organs" 05/01/2008 - "Allogeneic hematopoietic cell transplantation (HCT) is an increasingly widely used treatment modality in hematological malignancies" 05/01/2008 - "However, allogeneic hematopoietic cell transplantation (allo-HCT) still remains the sole curative therapy against chemotherapy-resistant hematological malignancies" Order ALL the reference details at left...
5.	Infection 12/01/2005 - "This overview summarizes recent data on emerging viruses after hematopoietic cell transplantation (HCT), including adenovirus, BK virus, human metapneumovirus (hMPV), and human herpesvirus (HHV) 6. The increased recognition of these infections is due to improved molecular detection methods, increased surveillance and more profound immunosuppression in the host" 09/01/2007 - "Our therapeutic design was based on data provided by both the use of Edmonton immunosuppressive steroid-free protocol in islets cell transplantation and the findings of international studies on the effects of this protocol in liver transplantation for patients with HCV infection" 12/01/2007 - "Organ/tissue/cell transplantation carries the risk of infection transfer from donor to recipient" 09/01/2007 - "The incidence of respiratory virus infection after hematopoietic cell transplantation (HCT) has probably been underestimated with conventional testing methods in symptomatic patients" 06/01/2007 - "Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Etoposide (VP 16)
2.	Cyclophosphamide (Cytoxan)
3.	Busulfan (Busulfex)
4.	Cyclosporine (Ciclosporin)
5.	Retinaldehyde (Retinal)
6.	Calcineurin
7.	Tacrolimus (Prograf)
8.	Methotrexate (Mexate)
9.	Nerve Growth Factor (NGF)
10.	Sirolimus (Rapamycin)

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)
2.	Transplants (Transplant)
3.	Drug Therapy (Chemotherapy)
4.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
5.	Stem Cell Transplantation

Best Treatments:
Research Summary Report
on Acute Myeloid Leukemia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1179 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>